Atherothrombotic complications are important causes of morbidity and mortality in diabetic patients. Diabetes has been considered to be a prothrombotic status. Several factors contribute to the prothrombotic condition, such as increasing coagulation, impaired fibrinolysis, endothelial dysfunction, and platelet hyperreactivity. Among the factors that contribute to the prothrombotic status in diabetes, altered platelet function plays a crucial role. Although understanding platelet function abnormalities in diabetes still remains as a challenge, more attention should be focused on platelet function for effective management and the prediction of atherothrombotic events in diabetic patients. This review will provide an overview on the current status of knowledge of platelet function abnormalities and clinical marker of platelet hyperreactivity in patients with diabetes.

Citations

Citations to this article as recorded by  

• Single nucleotide polymorphism rs7961894, platelet morphological parameters and lipid profile in children with type 1 diabetes: a potential relationship
  Mahmoud A. El-Hawy, Shimaa Abdelsattar, Hanan M. Bedair, Doaa Z. Elsaady, Ahmed S. Abo Hola
  European Journal of Pediatrics.2024;[Epub]     CrossRef
• Prediction of type 2 diabetes mellitus using hematological factors based on machine learning approaches: a cohort study analysis
  Amin Mansoori, Toktam Sahranavard, Zeinab Sadat Hosseini, Sara Saffar Soflaei, Negar Emrani, Eisa Nazar, Melika Gharizadeh, Zahra Khorasanchi, Sohrab Effati, Mark Ghamsary, Gordon Ferns, Habibollah Esmaily, Majid Ghayour Mobarhan
  Scientific Reports.2023;[Epub]     CrossRef
• Platelet P2Y1 receptor exhibits constitutive G protein signaling and β-arrestin 2 recruitment
  Agnès Ribes, Cédric Garcia, Marie-Pierre Gratacap, Evi Kostenis, Laurent O. Martinez, Bernard Payrastre, Jean-Michel Sénard, Céline Galés, Véronique Pons
  BMC Biology.2023;[Epub]     CrossRef
• Sex differences in the relationship between platelet count and type 2 diabetes risk in community‐dwelling adults: Longitudinal findings over 14 years
  Eun Kyeong Yun, In‐Ho Seo, Hye Sun Lee, So‐Young Seol, Yong‐Jae Lee
  Diabetes/Metabolism Research and Reviews.2023;[Epub]     CrossRef
• Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients
  Muttia Amalia, Meidi Utami Puteri, Fadlina Chany Saputri, Rani Sauriasari, Bambang Widyantoro
  Life.2023; 13(7): 1473.     CrossRef
• Effect of oral versus parenteral vitamin D3 supplementation on nuclear factor-κB and platelet aggregation in type 2 diabetic patients
  Esraa Habiba, Samia Ali, Yehia Ghanem, Ola Sharaki, Wafaa Hewedy
  Canadian Journal of Physiology and Pharmacology.2023; 101(11): 610.     CrossRef
• Characteristics of cerebral ischemic stroke based on moyamoya disease and atherosclerosis-associated intracranial arterial stenosis
  Zhiying Chen, Xiaoqin Wu, Da Zhou, Shuling Shang, Yuchuan Ding, Xunming Ji, Ran Meng
  Neurological Sciences.2022; 43(2): 1087.     CrossRef
• Basic Coagulation Profiles and Platelet Parameters Among Adult Type 1 and Type 2 Diabetes Patients at Dessie Referral Hospital, Northeast Ethiopia: Comparative Cross-Sectional Study
  Hussen Ebrahim, Fikir Asrie, Zegeye Getaneh
  Journal of Blood Medicine.2021; Volume 12: 33.     CrossRef
• Magnetic fields as a potential therapy for diabetic wounds based on animal experiments and clinical trials
  Huanhuan Lv, Junyu Liu, Chenxiao Zhen, Yijia Wang, Yunpeng Wei, Weihao Ren, Peng Shang
  Cell Proliferation.2021;[Epub]     CrossRef
• Diabetes and hypertension: Pivotal involvement of purinergic signaling
  Karine Paula Reichert, Milagros Fanny Vera Castro, Charles Elias Assmann, Nathieli Bianchin Bottari, Vanessa Valéria Miron, Andréia Cardoso, Naiara Stefanello, Vera Maria Melchiors Morsch, Maria Rosa Chitolina Schetinger
  Biomedicine & Pharmacotherapy.2021; 137: 111273.     CrossRef
• The hemostatic parameters in pregnant women with different types of diabetes mellitus
  R. V. Kapustin, E. V. Kopteeva, O. N. Arzhanova, A. V. Tiselko, N. Е. Androsova, T. I. Oparina
  Diabetes mellitus.2021; 24(3): 251.     CrossRef
• A study of activated platelet by flow cytometry in diabetic patients with peripheral arterial disease
  Maisa A. Abdel Wahab, Shaymaa A. Mohammed, Inass H. Ahmad, Salwa I. Elshennawy, Sadek Mostafa
  Al-Azhar Assiut Medical Journal.2021; 19(3): 395.     CrossRef
• Comparison of the progressive changes in hemogram parameters of normal glycemic and gestational diabetic patients throughout the first two trimesters and predictive ability of these indices for gestational diabetes mellitus
  Pelin AYTAN, Seyran BOZKURT BABUŞ, Özde SAKARYA, Revan Sabri ÇİFTÇİ, Kasım AKAY, Hakan AYTAN
  Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi.2020; 17(4): 533.     CrossRef
• A Pilot Study on the Effect of Anti-Thrombopoietin Antibody on Platelet Count in Patients with Type 2 Diabetes
  Takuya Fukuda, Masahide Hamaguchi, Takafumi Osaka, Yoshitaka Hashimoto, Emi Ushigome, Mai Asano, Masahiro Yamazaki, Eriko Fukuda, Kei Yamaguchi, Koji Ogawa, Naoki Goshima, Michiaki Fukui
  Molecules.2020; 25(7): 1667.     CrossRef
• Patient with diabetes after acute coronary event. How to improve forecast?
  O. L. Barbarash
  Medical alphabet.2019; 1(3): 6.     CrossRef
• Enhanced Platelet Sensitivity to IGF-1 in Patients with Type 2 Diabetes Mellitus
  N. Gligorijevic, D. Robajac, O. Nedic
  Biochemistry (Moscow).2019; 84(10): 1213.     CrossRef
• Comprehensive Quality Control of the Regenerative Therapy Using Platelet Concentrates: The Current Situation and Prospects in Japan
  Tomoyuki Kawase, Kazuhiro Okuda
  BioMed Research International.2018; 2018: 1.     CrossRef
• Changes in platelet morphology indices in relation to duration of disease and glycemic control in children with type 1 diabetes mellitus
  Vybhav Venkatesh, Rakesh Kumar, Dinesh Kumar Varma, Prateek Bhatia, Jaivinder Yadav, Devi Dayal
  Journal of Diabetes and its Complications.2018; 32(9): 833.     CrossRef
• Quantifying Platelet Margination in Diabetic Blood Flow
  Hung-Yu Chang, Alireza Yazdani, Xuejin Li, Konstantinos A.A. Douglas, Christos S. Mantzoros, George Em Karniadakis
  Biophysical Journal.2018; 115(7): 1371.     CrossRef
• Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion
  Giona Sonego, Mélanie Abonnenc, Jean-Daniel Tissot, Michel Prudent, Niels Lion
  International Journal of Molecular Sciences.2017; 18(2): 387.     CrossRef
• Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets
  Amanda J. Unsworth, Alexander P. Bye, Dionne S. Tannetta, Michael J.R. Desborough, Neline Kriek, Tanya Sage, Harriet E. Allan, Marilena Crescente, Parveen Yaqoob, Timothy D. Warner, Chris I. Jones, Jonathan M. Gibbins
  Arteriosclerosis, Thrombosis, and Vascular Biology.2017; 37(8): 1482.     CrossRef
• Aspirin in the prevention of cardiovascular events in patients with diabetes
  David S. H. Bell
  Postgraduate Medicine.2016; 128(2): 180.     CrossRef
• ROLE OF NITRIC OXIDE METABOLITES WITHIN THE IMPACT OF THE SUB-TOXIC SUCCINAMIDES DOSES ON STATE OF HEMOSTASIS
  I.А. Palagina, M.Y. Kudria, О.S. Lаlymеnkо
  Fiziolohichnyĭ zhurnal.2016; 62(6): 34.     CrossRef
• Influence of genetic variations in platelet glycoproteins and eNOS in the development of arterial ischaemia of lower limbs in type 2 diabetes mellitus patients
  Virginia Carvalhais, Ema Ruivães, Luis Bernardo Pina-Cabral, Bárbara Mesquita, Flávio Oliveira, Maria Céu Monteiro, Maria Begoña Criado
  The Foot.2016; 29: 42.     CrossRef
• Circulating endothelial progenitor cells and angiogenic factors in diabetes complicated diabetic foot and without foot complications
  Arleta Kulwas, Ewelina Drela, Wiesław Jundziłł, Barbara Góralczyk, Barbara Ruszkowska-Ciastek, Danuta Rość
  Journal of Diabetes and its Complications.2015; 29(5): 686.     CrossRef
• Cerebrovascular diseases: perspectives of pathogenetic metabolic haemangiocorrective treatment
  M. M. Tanashyan, O. V. Lagoda, K. V. Antonova
  Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2015; 115(9): 70.     CrossRef
• Letter: Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus (Diabetes Metab J2013;37:423-8)
  Cengiz Beyan, Esin Beyan
  Diabetes & Metabolism Journal.2014; 38(2): 158.     CrossRef
• Response: Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus (Diabetes Metab J2013;37:423-8)
  Jin Hwa Kim, Hak Yeon Bae, Sang Yong Kim
  Diabetes & Metabolism Journal.2014; 38(2): 160.     CrossRef